Nikko Asset Management Americas Inc. Reduces Position in COMPASS Pathways plc (NASDAQ:CMPS)

Nikko Asset Management Americas Inc. reduced its holdings in COMPASS Pathways plc (NASDAQ:CMPS) by 5.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 253,345 shares of the company’s stock after selling 16,024 shares during the period. Nikko Asset Management Americas Inc. owned approximately 0.37% of COMPASS Pathways worth $955,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. China Universal Asset Management Co. Ltd. acquired a new stake in COMPASS Pathways in the 4th quarter valued at about $41,000. Flagship Harbor Advisors LLC acquired a new stake in shares of COMPASS Pathways in the fourth quarter valued at approximately $43,000. Wealthfront Advisers LLC acquired a new stake in shares of COMPASS Pathways in the fourth quarter valued at approximately $43,000. Conservest Capital Advisors Inc. lifted its position in COMPASS Pathways by 28.9% during the fourth quarter. Conservest Capital Advisors Inc. now owns 13,363 shares of the company’s stock worth $51,000 after buying an additional 3,000 shares in the last quarter. Finally, Essential Planning LLC. acquired a new position in COMPASS Pathways during the fourth quarter worth $70,000. 46.19% of the stock is currently owned by institutional investors and hedge funds.

COMPASS Pathways Price Performance

COMPASS Pathways stock opened at $3.46 on Tuesday. The company’s 50 day simple moving average is $3.98 and its 200-day simple moving average is $4.95. The company has a debt-to-equity ratio of 0.15, a quick ratio of 8.91 and a current ratio of 8.91. COMPASS Pathways plc has a 1 year low of $3.17 and a 1 year high of $10.31. The company has a market capitalization of $320.65 million, a price-to-earnings ratio of -1.57 and a beta of 2.29.

COMPASS Pathways (NASDAQ:CMPS) last announced its earnings results on Thursday, February 27th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.01). As a group, equities research analysts expect that COMPASS Pathways plc will post -2.33 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on CMPS. Stifel Nicolaus started coverage on COMPASS Pathways in a research note on Thursday, February 27th. They issued a “buy” rating and a $11.00 target price for the company. Canaccord Genuity Group dropped their price objective on shares of COMPASS Pathways from $23.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $18.00 target price on shares of COMPASS Pathways in a research note on Wednesday, January 15th. Finally, HC Wainwright reissued a “buy” rating and issued a $45.00 price target on shares of COMPASS Pathways in a research note on Tuesday, March 4th. Seven analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $21.83.

About COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.